We are live on ! Find out more
CCG

Cypress Capital Group Portfolio holdings

AUM $889M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$890M
AUM Growth
+$55.4M
Cap. Flow
+$1.26M
Cap. Flow %
0.14%
Top 10 Hldgs %
33.32%
Holding
322
New
28
Increased
107
Reduced
160
Closed
12

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.58M
2
AVGO icon
Broadcom
AVGO
+$1.37M
3
URA icon
Global X Uranium ETF
URA
+$980K
4
INCY icon
Incyte
INCY
+$937K
5
META icon
Meta Platforms (Facebook)
META
+$936K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.27M
2
VZ icon
Verizon
VZ
+$1.21M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.14M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$964K
5
TXT icon
Textron
TXT
+$867K

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 16.44%
3 Financials 10.2%
4 Consumer Discretionary 8.09%
5 Industrials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
301
United Therapeutics
UTHR
$25.8B
$212K 0.02%
+591
New +$200K
MKL icon
302
Markel Group
MKL
$23.3B
$210K 0.02%
134
-5
-4% -$7.83K
XLP icon
303
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$210K 0.02%
+2,532
New +$203K
AZN icon
304
AstraZeneca
AZN
$263B
$206K 0.02%
+1,325
New +$214K
GEV icon
305
GE Vernova
GEV
$264B
$203K 0.02%
+798
New +$153K
VEU icon
306
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$202K 0.02%
+3,200
New +$193K
OMER icon
307
Omeros
OMER
$857M
$139K 0.02%
35,000
– –
ESBA icon
308
Empire State Realty Series ES
ESBA
$1.34B
$106K 0.01%
10,000
– –
CDZI icon
309
Cadiz
CDZI
$251M
$30.3K ﹤0.01%
10,000
– –
DNMR
310
DELISTED
Danimer Scientific, Inc.
DNMR
$21.6K ﹤0.01%
+1,190
New +$20.8K
BA icon
311
Boeing
BA
$171B
– –
-2,687
Closed -$489K
CF icon
312
CF Industries
CF
$19.2B
– –
-7,369
Closed -$546K
CMG icon
313
Chipotle Mexican Grill
CMG
$47.2B
– –
-3,200
Closed -$200K
CNP icon
314
CenterPoint Energy
CNP
$27.7B
– –
-6,554
Closed -$203K
DXCM icon
315
DexCom
DXCM
$32.2B
– –
-2,104
Closed -$239K
ELV icon
316
Elevance Health
ELV
$81.5B
– –
-501
Closed -$271K
HUM icon
317
Humana
HUM
$43.7B
– –
-793
Closed -$296K
IWP icon
318
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
– –
-1,858
Closed -$205K
IWS icon
319
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
– –
-1,717
Closed -$207K
TXT icon
320
Textron
TXT
$14.7B
– –
-10,102
Closed -$867K
UBER icon
321
Uber
UBER
$143B
– –
-2,833
Closed -$206K
VATE icon
322
INNOVATE Corp
VATE
$111M
– –
-1,200
Closed -$7.25K
9 10 11 12
13

Similar funds

KWM
Keebeck Wealth Management Chicago, Illinois $889M AUM 20.87% 1-Year Est. Return
FCM
FJ Capital Management Mclean, Virginia $888M AUM 18.97% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $891M AUM 17.3% 1-Year Est. Return
PCM
Prime Capital Management Hong Kong $891M AUM 83.14% 1-Year Est. Return
SFM
Signet Financial Management Parsippany, New Jersey $892M AUM 23.24% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return
BFFIM
Baring Fintech Fund III Managers St Peter Port, Guernsey $893M AUM 20.23% 1-Year Est. Return
MFWM
Motley Fool Wealth Management Alexandria, Virginia $884M AUM 5.86% 1-Year Est. Return

Cypress Capital Group's Q3 2024 Portfolio in Review

As of Q3 2024, Cypress Capital Group held 322 positions worth $890M, up 6.6% from $834M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Cypress Capital Group's Q3 2024 filing shows 28 new, 107 increased, 160 reduced and 12 closed positions. Its largest new stake was Advanced Micro Devices: 10,380 shares worth $1.7M. The largest sale was Eli Lilly, an estimated $1.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Cypress Capital Group's largest Q3 2024 buy was Advanced Micro Devices: 10,380 shares worth $1.7M.
  • Cypress Capital Group added most to Broadcom in Q3 2024, an estimated $1.37M increase.
  • Cypress Capital Group's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.27M.
  • Cypress Capital Group fully exited Textron in Q3 2024, selling an estimated $867K.
  • Cypress Capital Group's ten largest holdings make up 33% of its $890M portfolio in Q3 2024.
  • Cypress Capital Group opened 28 new positions and closed 12 in Q3 2024.
  • Cypress Capital Group's portfolio value rose 6.6% quarter-over-quarter to $890M.

Based on Cypress Capital Group's 13F filing for Q3 2024, filed 8 Nov 2024.